No one should be offered sub-standard aneuploidy screening simply because of their body size. So proud of my colleagues at Myriad Women's Health for developing this technology that amplifies cell-free fetal DNA and avoids the pitfalls of low fetal fraction.

"Due to changing demographics and increased intergroup marriage, the risk of passing along genetic diseases is no longer concentrated in specific ethnicities." -Dale Muzzy, our VP of Bioinformatics. Learn more about our study in Genetics in Medicine: bddy.me/2XLAt2l

The health care community has lots of work to do to improve health disparities. One simple action is to rewrite guidelines that perpetuate disparities. Ethnicity-based carrier screening guidelines do not serve all patients equally. The evidence is clear: time to offer ECS to all.

Do you ever wonder what conditions would be on an expanded carrier screening panel that conservatively follows ACOG panel design criteria? Find out during my #ASRM2020 virtual poster session today at 1:30pmPT! Poster P-623.

I’m privileged to work with so many talented genetic counselors Myriad Women's Health and many other places. Thank you for all you do!

For folks out there following the latest in noninvasive prenatal screening, this one is a game-changer: nature.com/articles/s4143…. Fetal fraction amplification makes low fetal fraction issues a thing of the past and improves care for pregnant women.

Nice article by SWHR highlighting the importance of technologies that provide equitable prenatal genetic screening. Every patient wishing to be screened should have access to the most comprehensive and accurate tests, no matter their ethnicity or body size.

Today is National Phenylketonuria (PKU) Day! Read our most recent blog about the Ahern’s journey with PKU: bddy.me/39HfXqw #raredisease #PKUAwareness

A technique modification to provide nearly all women with confident results using NIPS: fetal fraction amplification with WGS–based NIPS go.nature.com/3lIHbiO #noninvasiveprenatalscreening #prenatal #genetictesting #Genetics

Join ACMG for a FREE symposium, “2021 Updates in #HealthDisparities in Medical Genetics,” May 14, 2021. For more information and to register, go to the ACMG Genetics Academy: acmgeducation.net/URL/ACMGHealth… #diversity #equity #inclusion #DEI #minorityhealth #MedicalGeneticsAwareness

Myriad Women’s Health is proud to support the American College of Medical Genetics Symposium, 2021 Updates in Health Disparities in Medical Genetics on May 14th. Register for this free event with CE credits available at: bddy.me/2SGNUAR

Sickle cell is one example of hundreds of conditions that couples deserve to know their baby may have. ACMG recommends carrier screening for >100 conditions. Consensus by ACOG is needed to build provider awareness and insurance coverage. nytimes.com/2021/12/28/hea…

Proud to have worked with current and former Myriad Genetics colleagues to apply ACOG and ACMG carrier screening panel criteria to identify a guidelines-consistent panel that equitably identifies couples at risk, regardless of ethnicity.

Noninvasive prenatal screening (NIPS) is NOT prenatal diagnosis. Conflation of these two terms is still happening, even at #ACMGMtg22, and perpetuates confusion among patrons and providers.